# SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis

> **NCT06047964** · NA · ACTIVE_NOT_RECRUITING · sponsor: **B. Braun Medical International Trading Company Ltd.** · enrollment: 281 (actual)

## Conditions studied

- Stroke
- Intracranial Atherosclerotic Stenosis

## Interventions

- **DEVICE:** DCB
- **DEVICE:** POBA

## Key facts

- **NCT ID:** NCT06047964
- **Lead sponsor:** B. Braun Medical International Trading Company Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2023-03-23
- **Primary completion:** 2024-09-29
- **Final completion:** 2025-01-23
- **Target enrollment:** 281 (ACTUAL)
- **Last updated:** 2024-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06047964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06047964, "SeQuent ® Please CIS for the Treatment of INtracranial Atherosclerotic Stenosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06047964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*